Ohio Pen - Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025 USA - English USA - English

Trending...

OXFORD, England and CLEVELAND, Sept. 10, 2025 ~ New York City - On Tuesday, September 9, 2025, Lord Cameron, former UK Prime Minister and Chair of the Oxford-Harrington Rare Disease Centre (OHC) Advisory Council, was a featured guest speaker at the Morgan Stanley Exchange 2025 conference. The conference, held in New York City, brought together leaders in philanthropy, healthcare, and innovation to explore bold ideas for addressing global challenges.

Lord Cameron joined Andy Saperstein, Co-President of Morgan Stanley, for an intimate dialogue entitled "A Conversation on Courage". The session delved into topics such as leadership and philanthropy and their shared commitment to advancing progress in rare disease research and treatment.

As Chair of the OHC Advisory Council, Lord Cameron leads international efforts to achieve the Centre's ambitious goal of delivering 40 new rare disease treatments by 2034. This mission is deeply personal for Lord Cameron as it is rooted in his family's own experience with rare disease. He also played a crucial role in founding Genomics England and the groundbreaking 100,000 Genomes Project.

In his speech at Exchange 2025, Lord Cameron expressed his dedication to this cause stating that "Of the causes I have advocated for, this one is personal." He went on to highlight the OHC's unique approach of bringing together academia, life sciences, philanthropy, and industry to provide hope for millions worldwide living with rare diseases.

More on Ohio Pen

Andy Saperstein also praised Lord Cameron's leadership at the OHC stating that "His [Lord Cameron] leadership highlights how collaboration across science, philanthropy and investment can transform the future for millions of patients worldwide." He also emphasized Morgan Stanley's belief in the power of courageous ideas and their partnership with Harrington Discovery Institute to drive new cures.

The Morgan Stanley Exchange conference aims to bridge funding gaps by convening leading institutions, funders and innovators. Lord Cameron's participation underscored the importance of investment, partnership, and the role of philanthropy in delivering new treatments for rare diseases.

The conference also featured a photo of Lord Cameron alongside Andy Saperstein and Melanie Schnoll Begun, Head of Family Office Resources Field Engagement and Philanthropy Management at Morgan Stanley. The photo captured the spirit of collaboration and determination to find solutions for rare diseases.

The OHC is a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio. Their mission is to create new medicines for rare diseases and provide hope for millions worldwide. With Lord Cameron's leadership and the support of institutions like Morgan Stanley, they are well on their way to achieving their goal of delivering 40 new treatments by 2034.

Filed Under: Business

0 Comments

Latest on Ohio Pen